---
figid: PMC11011199__cancers-16-01364-g002
figtitle: 'Prediction of Response to Anti-Angiogenic Treatment for Advanced Colorectal
  Cancer Patients: From Biological Factors to Functional Imaging'
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC11011199
filename: cancers-16-01364-g002.jpg
figlink: /pmc/articles/PMC11011199/figure/cancers-16-01364-f002/
number: F2
caption: 'Angiogenesis pathway. The interaction between VEGF and VEGFR leads to the
  activation of downstream signaling which ultimately results in angiogenesis activation.
  Specific anti-angiogenic drugs such as bevacizumab, ramucirumab, aflibercept, and
  regorafenib block angiogenic cascade activation. Abbreviations: AKT/PKB: Protein
  Kinase B; BAD: BCL2 Associated Agonist Of Cell Death; Ca2+: Calcium ions; c-FOS:
  human homolog of the retroviral oncogene v-fos (FBJ murine osteosarcoma viral oncogene
  homolog); cPLA: Cytosolic phospholipase A; DAG: diacylglycerol; e-NOS: Endothelial-nitric
  oxide synthase 3; ERK: extracellular signal-regulated kinase; FAK: focal adhesion
  kinase; GRB2: Growth factor receptor-bound protein 2; HSP: heat shock proteins;
  IP3: Inositol trisphosphate; MAPK: mitogen-activated protein kinase; MEK: mitogen-activated
  protein kinase kinase; MKK3/6: mitogen-activated kinase kinases; PI3K: phosphatidylinositol
  3-kinases; PIP: phosphatidylinositol phosphate; PKC: Protein kinase C; PLC: phospholipase
  C; PTEN: Phosphatase and tensin homolog, RAF: proto-oncogene serine/threonine-protein
  kinase; RAS: rat sarcoma; Sck: Shc-related adaptor protein; SHC: Src homology 2
  domain containing; SOS: son of sevenless; SRC: Proto-oncogene tyrosine-protein kinase
  Src; VRAP: VEGFR-associated protein; VEGF: vascular endothelial growth factor; VEGFR2:
  vascular endothelial growth factor receptor-2.'
papertitle: 'Prediction of Response to Anti-Angiogenic Treatment for Advanced Colorectal
  Cancer Patients: From Biological Factors to Functional Imaging.'
reftext: Giuseppe Corrias, et al. Cancers (Basel). 2024 Apr;16(7):1364.
year: '2024'
doi: 10.3390/cancers16071364
journal_title: Cancers
journal_nlm_ta: Cancers (Basel)
publisher_name: MDPI
keywords: metastatic colorectal cancer | angiogenesis | anti-angiogenic treatment
  | prediction of response | biologic factors | radiomics
automl_pathway: 0.8568379
figid_alias: PMC11011199__F2
figtype: Figure
redirect_from: /figures/PMC11011199__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC11011199__cancers-16-01364-g002.html
  '@type': Dataset
  description: 'Angiogenesis pathway. The interaction between VEGF and VEGFR leads
    to the activation of downstream signaling which ultimately results in angiogenesis
    activation. Specific anti-angiogenic drugs such as bevacizumab, ramucirumab, aflibercept,
    and regorafenib block angiogenic cascade activation. Abbreviations: AKT/PKB: Protein
    Kinase B; BAD: BCL2 Associated Agonist Of Cell Death; Ca2+: Calcium ions; c-FOS:
    human homolog of the retroviral oncogene v-fos (FBJ murine osteosarcoma viral
    oncogene homolog); cPLA: Cytosolic phospholipase A; DAG: diacylglycerol; e-NOS:
    Endothelial-nitric oxide synthase 3; ERK: extracellular signal-regulated kinase;
    FAK: focal adhesion kinase; GRB2: Growth factor receptor-bound protein 2; HSP:
    heat shock proteins; IP3: Inositol trisphosphate; MAPK: mitogen-activated protein
    kinase; MEK: mitogen-activated protein kinase kinase; MKK3/6: mitogen-activated
    kinase kinases; PI3K: phosphatidylinositol 3-kinases; PIP: phosphatidylinositol
    phosphate; PKC: Protein kinase C; PLC: phospholipase C; PTEN: Phosphatase and
    tensin homolog, RAF: proto-oncogene serine/threonine-protein kinase; RAS: rat
    sarcoma; Sck: Shc-related adaptor protein; SHC: Src homology 2 domain containing;
    SOS: son of sevenless; SRC: Proto-oncogene tyrosine-protein kinase Src; VRAP:
    VEGFR-associated protein; VEGF: vascular endothelial growth factor; VEGFR2: vascular
    endothelial growth factor receptor-2.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - BAD
  - VEGFA
  - VEGFB
  - VEGFC
  - VEGFD
  - PGF
  - PTEN
  - HSPG2
  - PLCE1
  - PLCZ1
  - PLCB1
  - PLCB2
  - PLCB3
  - PLCB4
  - PLCD1
  - PLCD3
  - PLCD4
  - PLCG1
  - PLCG2
  - KDR
  - SRC
  - FGR
  - FYN
  - YES1
  - MAP2K3
  - MAP2K6
  - SHC2
  - AKT1
  - AKT2
  - AKT3
  - PTK2B
  - PTK2
  - GRB2
  - XYLT2
  - SOS1
  - SOS2
  - CRK
  - MAPK14
  - MAPK1
  - AIMP2
  - GRAP2
  - AHSA1
  - POLDIP2
  - MAPK11
  - MAPK12
  - MAPK13
  - SHC1
  - SHC3
  - SHC4
  - MAPK3
  - MAPK8
  - MAPK9
  - MAPK10
  - NOS3
  - ENO4
  - HSP90AA1
  - HSP90B1
  - TRAP1
  - HSP90AB1
  - CASP1
  - CASP2
  - CASP4
  - CASP5
  - CASP6
  - CASP8
  - CASP9
  - CASP10
  - CASP12
  - CASP14
  - CASP3
  - CASP7
  - HSPB1
  - HSPB2
  - ACTA1
  - ACTA2
  - ACTB
  - ACTC1
  - ACTG1
  - ACTG2
  - PRRT2
  - PRKCA
  - PRKCB
  - PRKCD
  - PRKCE
  - PRKCG
  - PRKCH
  - PRKCI
  - PRKCQ
  - PRKCZ
  - PRKD3
  - KRAS
  - HRAS
  - NRAS
  - RAF1
  - RNASE3
  - MAP2K1
  - MAP2K2
  - FOS
  - REGORAFENIB
  - Prostaglandin
  - RAS
---
